Overview

Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

Gastric cancer radical surgery related complications are common.Somatostatin is a conventional medical therapy for bleeding.This study explore the effect of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node dissection.

Phase:

Phase 4

Details

Lead Sponsor:

First Affiliated Hospital, Sun Yat-Sen University

Treatments:

Somatostatin